Skip to main content
Top
Published in: Acta Neuropathologica 6/2011

01-12-2011 | Case Report

An autopsy case of adult-onset hereditary spastic paraplegia type 2 with a novel mutation in exon 7 of the proteolipid protein 1 gene

Authors: Satoshi O. Suzuki, Toru Iwaki, Kenji Arakawa, Hirokazu Furuya, Naoki Fujii, Akiko Iwaki

Published in: Acta Neuropathologica | Issue 6/2011

Login to get access

Abstract

We report an autopsy case of rare adult-onset spastic paraplegia type 2 (SPG2) with a novel missense mutation in exon 7 of the proteolipid protein 1 gene (PLP1). The patient was a 67-year-old man whose elder brother had died of a similar disease with onset in his 40s. Thirty-three years before death at the age of 35, he noticed difficulty in walking. He gradually became abasic over a period of 6 years. He also developed progressive dementia and eventually became bed-ridden by 28 years after onset. At autopsy, gross inspection revealed diffuse, moderate atrophy of the cerebrum with a dilated ventricular system and softening of the white matter throughout the central nervous system (CNS). Histopathologically, the CNS showed widespread myelin pallor in the white matter. By contrast, the gray matter and peripheral nerves were well preserved. Some white matter tracts, including the corticospinal tracts, were preferentially affected, and severe axonal degeneration was observed in these tracts. Genetic analysis revealed a novel mutation, p.Tyr263Cys, in exon 7 of PLP1. This case represents an adult-onset SPG2 patient with one of the oldest ages of onset reported to date. The late onset and long clinical course suggest that this novel mutation does not affect the maturation of oligodendrocytes, but is related to insufficient maintenance of myelin.
Literature
1.
go back to reference Cailloux F, Gauthier-Barichard F, Mimault C et al (2000) Genotype-phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations. Clinical European network on brain dysmyelinating disease. Eur J Hum Genet 8:837–845PubMedCrossRef Cailloux F, Gauthier-Barichard F, Mimault C et al (2000) Genotype-phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations. Clinical European network on brain dysmyelinating disease. Eur J Hum Genet 8:837–845PubMedCrossRef
2.
go back to reference Fink JK, Heiman-Patterson T, Bird T et al (1996) Hereditary spastic paraplegia: advances in genetic research. Hereditary Spastic Paraplegia Working group. Neurology 46:1507–1514PubMed Fink JK, Heiman-Patterson T, Bird T et al (1996) Hereditary spastic paraplegia: advances in genetic research. Hereditary Spastic Paraplegia Working group. Neurology 46:1507–1514PubMed
3.
go back to reference Garbern JY (2007) Pelizaeus-Merzbacher disease: genetic and cellular pathogenesis. Cell Mol Life Sci 64:50–65PubMedCrossRef Garbern JY (2007) Pelizaeus-Merzbacher disease: genetic and cellular pathogenesis. Cell Mol Life Sci 64:50–65PubMedCrossRef
4.
go back to reference Garbern JY, Yool DA, Moore GJ et al (2002) Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 125:551–561PubMedCrossRef Garbern JY, Yool DA, Moore GJ et al (2002) Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 125:551–561PubMedCrossRef
5.
go back to reference Gow A, Friedrich VL Jr, Lazzarini RA (1994) Many naturally occurring mutations of myelin proteolipid protein impair its intracellular transport. J Neurosci Res 37:574–583PubMedCrossRef Gow A, Friedrich VL Jr, Lazzarini RA (1994) Many naturally occurring mutations of myelin proteolipid protein impair its intracellular transport. J Neurosci Res 37:574–583PubMedCrossRef
6.
go back to reference Gow A, Lazzarini RA (1996) A cellular mechanism governing the severity of Pelizaeus–Merzbacher disease. Nat Genet 13:422–428PubMedCrossRef Gow A, Lazzarini RA (1996) A cellular mechanism governing the severity of Pelizaeus–Merzbacher disease. Nat Genet 13:422–428PubMedCrossRef
7.
go back to reference Gow A, Sharma R (2003) The unfolded protein response in protein aggregating diseases. Neuromol Med 4:73–94CrossRef Gow A, Sharma R (2003) The unfolded protein response in protein aggregating diseases. Neuromol Med 4:73–94CrossRef
8.
go back to reference Griffiths I, Klugmann M, Anderson T et al (1998) Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280:1610–1613PubMedCrossRef Griffiths I, Klugmann M, Anderson T et al (1998) Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280:1610–1613PubMedCrossRef
9.
go back to reference Grossi S, Regis S, Biancheri R et al (2011) Molecular genetic analysis of the PLP1 Gene in 38 families with PLP1-related disorders: identification and functional characterization of 11 Novel PLP1 mutations. Orphanet J Rare Dis 6:40PubMedCrossRef Grossi S, Regis S, Biancheri R et al (2011) Molecular genetic analysis of the PLP1 Gene in 38 families with PLP1-related disorders: identification and functional characterization of 11 Novel PLP1 mutations. Orphanet J Rare Dis 6:40PubMedCrossRef
10.
go back to reference Hodes ME, Blank CA, Pratt VM, Morales J, Napier J, Dlouhy SR (1997) Nonsense mutation in exon 3 of the proteolipid protein gene (PLP) in a family with an unusual form of Pelizaeus–Merzbacher disease. Am J Med Genet 69:121–125PubMedCrossRef Hodes ME, Blank CA, Pratt VM, Morales J, Napier J, Dlouhy SR (1997) Nonsense mutation in exon 3 of the proteolipid protein gene (PLP) in a family with an unusual form of Pelizaeus–Merzbacher disease. Am J Med Genet 69:121–125PubMedCrossRef
11.
go back to reference Hodes ME, Zimmerman AW, Aydanian A et al (1999) Different mutations in the same codon of the proteolipid protein gene, PLP, may help in correlating genotype with phenotype in Pelizaeus–Merzbacher disease/X-linked spastic paraplegia (PMD/SPG2). Am J Med Genet 82:132–139PubMedCrossRef Hodes ME, Zimmerman AW, Aydanian A et al (1999) Different mutations in the same codon of the proteolipid protein gene, PLP, may help in correlating genotype with phenotype in Pelizaeus–Merzbacher disease/X-linked spastic paraplegia (PMD/SPG2). Am J Med Genet 82:132–139PubMedCrossRef
12.
go back to reference Hudson LD, Berndt JA, Puckett C, Kozak CA, Lazzarini RA (1987) Aberrant splicing of proteolipid protein mRNA in the dysmyelinating jimpy mutant mouse. Proc Natl Acad Sci USA 84:1454–1458PubMedCrossRef Hudson LD, Berndt JA, Puckett C, Kozak CA, Lazzarini RA (1987) Aberrant splicing of proteolipid protein mRNA in the dysmyelinating jimpy mutant mouse. Proc Natl Acad Sci USA 84:1454–1458PubMedCrossRef
13.
go back to reference Hudson LD, Friedrich VL Jr, Behar T, Dubois-Dalcq M, Lazzarini RA (1989) The initial events in myelin synthesis: orientation of proteolipid protein in the plasma membrane of cultured oligodendrocytes. J Cell Biol 109:717–727PubMedCrossRef Hudson LD, Friedrich VL Jr, Behar T, Dubois-Dalcq M, Lazzarini RA (1989) The initial events in myelin synthesis: orientation of proteolipid protein in the plasma membrane of cultured oligodendrocytes. J Cell Biol 109:717–727PubMedCrossRef
14.
go back to reference Inoue K (2005) PLP1-related inherited dysmyelinating disorders: Pelizaeus–Merzbacher disease and spastic paraplegia type 2. Neurogenetics 6:1–16PubMedCrossRef Inoue K (2005) PLP1-related inherited dysmyelinating disorders: Pelizaeus–Merzbacher disease and spastic paraplegia type 2. Neurogenetics 6:1–16PubMedCrossRef
15.
go back to reference Iwaki A, Muramoto T, Iwaki I et al (1993) A missense mutation in the proteolipid protein gene responsible for Pelizaeus–Merzbacher disease in a Japanese family. Hum Mol Genet 2:19–22PubMedCrossRef Iwaki A, Muramoto T, Iwaki I et al (1993) A missense mutation in the proteolipid protein gene responsible for Pelizaeus–Merzbacher disease in a Japanese family. Hum Mol Genet 2:19–22PubMedCrossRef
16.
go back to reference Kobayashi H, Hoffman EP, Marks HG (1994) The rumpshaker mutation in spastic paraplegia. Nat Genet 7:351–352PubMedCrossRef Kobayashi H, Hoffman EP, Marks HG (1994) The rumpshaker mutation in spastic paraplegia. Nat Genet 7:351–352PubMedCrossRef
17.
go back to reference Kurosawa K, Iwaki A, Miyake S, Imaizumi K, Kuroki Y, Fukumaki Y (1993) A novel insertional mutation at exon VII of the myelin proteolipid protein gene in Pelizaeus–Merzbacher disease. Hum Mol Genet 2:2187–2189PubMedCrossRef Kurosawa K, Iwaki A, Miyake S, Imaizumi K, Kuroki Y, Fukumaki Y (1993) A novel insertional mutation at exon VII of the myelin proteolipid protein gene in Pelizaeus–Merzbacher disease. Hum Mol Genet 2:2187–2189PubMedCrossRef
18.
go back to reference Lee ES, Moon HK, Park YH, Garbern J, Hobson GM (2004) A case of complicated spastic paraplegia 2 due to a point mutation in the proteolipid protein 1 gene. J Neurol Sci 224:83–87PubMedCrossRef Lee ES, Moon HK, Park YH, Garbern J, Hobson GM (2004) A case of complicated spastic paraplegia 2 due to a point mutation in the proteolipid protein 1 gene. J Neurol Sci 224:83–87PubMedCrossRef
19.
go back to reference Osaka H, Koizume S, Aoyama H et al (2010) Mild phenotype in Pelizaeus–Merzbacher disease caused by a PLP1-specific mutation. Brain Dev 32:703–707PubMedCrossRef Osaka H, Koizume S, Aoyama H et al (2010) Mild phenotype in Pelizaeus–Merzbacher disease caused by a PLP1-specific mutation. Brain Dev 32:703–707PubMedCrossRef
20.
go back to reference Saugier-Veber P, Munnich A, Bonneau D et al (1994) X-linked spastic paraplegia and Pelizaeus–Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat Genet 6:257–262PubMedCrossRef Saugier-Veber P, Munnich A, Bonneau D et al (1994) X-linked spastic paraplegia and Pelizaeus–Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat Genet 6:257–262PubMedCrossRef
21.
go back to reference Sima AA, Pierson CR, Woltjer RL et al (2009) Neuronal loss in Pelizaeus–Merzbacher disease differs in various mutations of the proteolipid protein 1. Acta Neuropathol 118:531–539PubMedCrossRef Sima AA, Pierson CR, Woltjer RL et al (2009) Neuronal loss in Pelizaeus–Merzbacher disease differs in various mutations of the proteolipid protein 1. Acta Neuropathol 118:531–539PubMedCrossRef
22.
go back to reference Sivakumar K, Sambuughin N, Selenge B et al (1999) Novel exon 3B proteolipid protein gene mutation causing late–onset spastic paraplegia type 2 with variable penetrance in female family members. Ann Neurol 45:680–683PubMedCrossRef Sivakumar K, Sambuughin N, Selenge B et al (1999) Novel exon 3B proteolipid protein gene mutation causing late–onset spastic paraplegia type 2 with variable penetrance in female family members. Ann Neurol 45:680–683PubMedCrossRef
23.
go back to reference Southwood CM, Garbern J, Jiang W, Gow A (2002) The unfolded protein response modulates disease severity in Pelizaeus–Merzbacher disease. Neuron 36:585–596PubMedCrossRef Southwood CM, Garbern J, Jiang W, Gow A (2002) The unfolded protein response modulates disease severity in Pelizaeus–Merzbacher disease. Neuron 36:585–596PubMedCrossRef
24.
go back to reference Thomson CE, Montague P, Jung M, Nave KA, Griffiths IR (1997) Phenotypic severity of murine Plp mutants reflects in vivo and in vitro variations in transport of PLP isoproteins. Glia 20:322–332PubMedCrossRef Thomson CE, Montague P, Jung M, Nave KA, Griffiths IR (1997) Phenotypic severity of murine Plp mutants reflects in vivo and in vitro variations in transport of PLP isoproteins. Glia 20:322–332PubMedCrossRef
25.
go back to reference Woodward KJ (2008) The molecular and cellular defects underlying Pelizaeus–Merzbacher disease. Expert Rev Mol Med 10:e14PubMedCrossRef Woodward KJ (2008) The molecular and cellular defects underlying Pelizaeus–Merzbacher disease. Expert Rev Mol Med 10:e14PubMedCrossRef
Metadata
Title
An autopsy case of adult-onset hereditary spastic paraplegia type 2 with a novel mutation in exon 7 of the proteolipid protein 1 gene
Authors
Satoshi O. Suzuki
Toru Iwaki
Kenji Arakawa
Hirokazu Furuya
Naoki Fujii
Akiko Iwaki
Publication date
01-12-2011
Publisher
Springer-Verlag
Published in
Acta Neuropathologica / Issue 6/2011
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-011-0916-x

Other articles of this Issue 6/2011

Acta Neuropathologica 6/2011 Go to the issue